PortfoliosLab logoPortfoliosLab logo
PYPL vs. PACB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PYPL vs. PACB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PayPal Holdings, Inc. (PYPL) and Pacific Biosciences of California, Inc. (PACB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PYPL achieves a -28.41% return, which is significantly higher than PACB's -29.95% return. Over the past 10 years, PYPL has outperformed PACB with an annualized return of 1.21%, while PACB has yielded a comparatively lower -17.53% annualized return.


PYPL

1D
0.70%
1M
-6.18%
YTD
-28.41%
6M
-32.22%
1Y
-40.86%
3Y*
-12.98%
5Y*
-31.18%
10Y*
1.21%

PACB

1D
-2.96%
1M
8.26%
YTD
-29.95%
6M
-38.21%
1Y
9.17%
3Y*
-54.65%
5Y*
-46.26%
10Y*
-17.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PYPL vs. PACB - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PYPL
PayPal Holdings, Inc.
-28.41%-31.44%38.98%-13.77%-62.23%-19.48%116.51%28.64%14.22%86.52%
PACB
Pacific Biosciences of California, Inc.
-29.95%2.19%-81.35%19.93%-60.02%-21.13%404.67%-30.54%180.30%-30.53%

Correlation

The correlation between PYPL and PACB is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.32

Correlation (5Y)
Calculated over the trailing 5-year period

0.43

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jul 20, 2015

0.34

The correlation between PYPL and PACB shifts across timeframes, from 0.23 (1 year) to 0.43 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PYPL:

$38.21B

PACB:

$400.62M

EPS

PYPL:

$5.31

PACB:

-$0.43

PS Ratio

PYPL:

1.17

PACB:

2.47

PB Ratio

PYPL:

1.91

PACB:

3.82

Total Revenue (TTM)

PYPL:

$33.73B

PACB:

$160.03M

Gross Profit (TTM)

PYPL:

$15.56B

PACB:

$59.34M

EBITDA (TTM)

PYPL:

$7.23B

PACB:

-$146.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PYPL vs. PACB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PYPL
PYPL Risk / Return Rank: 55
Overall Rank
PYPL Sharpe Ratio Rank: 33
Sharpe Ratio Rank
PYPL Sortino Ratio Rank: 66
Sortino Ratio Rank
PYPL Omega Ratio Rank: 55
Omega Ratio Rank
PYPL Calmar Ratio Rank: 88
Calmar Ratio Rank
PYPL Martin Ratio Rank: 66
Martin Ratio Rank

PACB
PACB Risk / Return Rank: 4949
Overall Rank
PACB Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
PACB Sortino Ratio Rank: 5353
Sortino Ratio Rank
PACB Omega Ratio Rank: 5050
Omega Ratio Rank
PACB Calmar Ratio Rank: 4848
Calmar Ratio Rank
PACB Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PYPL vs. PACB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PayPal Holdings, Inc. (PYPL) and Pacific Biosciences of California, Inc. (PACB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PYPLPACBDifference
Sharpe ratioReturn per unit of total volatility

-1.25

Sortino ratioReturn per unit of downside risk

-2.40

Omega ratioGain probability vs. loss probability

0.79

1.09

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.88

0.19

-1.07

Martin ratioReturn relative to average drawdown

-1.54

0.36

-1.90

PYPL vs. PACB - Sharpe Ratio Comparison

The current PYPL Sharpe Ratio is -1.13, which is lower than the PACB Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of PYPL and PACB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PYPL vs. PACB - Drawdown Comparison

The maximum PYPL drawdown since its inception was -87.30%, smaller than the maximum PACB drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for PYPL and PACB.


Loading charts...

Drawdown Indicators


PYPLPACBDifference

Max Drawdown

Largest peak-to-trough decline

-87.30%

-98.22%

+10.92%

Max Drawdown (1Y)

Largest decline over 1 year

-49.92%

-58.05%

+8.13%

Max Drawdown (3Y)

Largest decline over 3 years

-57.34%

-93.47%

+36.13%

Max Drawdown (5Y)

Largest decline over 5 years

-87.30%

-97.47%

+10.17%

Max Drawdown (10Y)

Largest decline over 10 years

-87.30%

-98.22%

+10.92%

Current Drawdown

Current decline from peak

-86.42%

-97.44%

+11.02%

Average Drawdown

Average peak-to-trough decline

-35.90%

-70.53%

+34.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.60%

30.69%

-2.09%

Volatility

PYPL vs. PACB - Volatility Comparison

The current volatility for PayPal Holdings, Inc. (PYPL) is 7.01%, while Pacific Biosciences of California, Inc. (PACB) has a volatility of 23.75%. This indicates that PYPL experiences smaller price fluctuations and is considered to be less risky than PACB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PYPLPACBDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.01%

23.75%

-16.74%

Volatility (6M)

Calculated over the trailing 6-month period

31.72%

56.74%

-25.02%

Volatility (1Y)

Calculated over the trailing 1-year period

39.10%

88.70%

-49.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.08%

94.39%

-52.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.77%

84.71%

-45.94%

Dividends

PYPL vs. PACB - Dividend Comparison

PYPL's dividend yield for the trailing twelve months is around 1.01%, while PACB has not paid dividends to shareholders.


PositionTTM2025
PACB
Pacific Biosciences of California, Inc.
0.00%0.00%
PYPL
PayPal Holdings, Inc.
1.01%0.24%

Financials

PYPL vs. PACB - Financials Comparison

This section allows you to compare key financial metrics between PayPal Holdings, Inc. and Pacific Biosciences of California, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
8.35B
37.18M
(PYPL) Total Revenue
(PACB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PYPL and PACB have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PACB has higher volatility (23.75%) compared to PYPL (7.01%). In terms of maximum drawdown, PYPL dropped -87.30% vs PACB's -98.22%.

PACB currently has the higher Sharpe Ratio (0.12 vs -1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PYPL and PACB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer